Acrizanib
Product Specifications
UNSPSC Description
Acrizanib (LHA510) is a VEGFR-2 inhibitor, with an IC50 of 17.4 nM for BaF3-VEGFR-2[1].
Target Antigen
VEGFR
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/Acrizanib.html
Purity
99.84
Solubility
DMSO : 41.67 mg/mL (ultrasonic)
Smiles
O=C(N1C2=CC=C(OC3=NC=NC(CNC)=C3)C=C2C=C1)NC4=NN(C)C(C(F)(F)F)=C4
Molecular Weight
445.40
References & Citations
[1]Adams CM, et al. The Discovery of N-(1-Methyl-5-(trifluoromethyl)-1H-pyrazol-3-yl)-5-((6- ((methylamino)methyl)pyrimidin-4-yl)oxy)-1H-indole-1-carboxamide (Acrizanib), a VEGFR-2 Inhibitor Specifically Designed for Topical Ocular Delivery, as a Therapy for Neovascular Age-Related Macular Degeneration. J Med Chem. 2018 Feb 22;61(4):1622-1635.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-109020/Acrizanib-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-109020/Acrizanib-SDS-MedChemExpress.pdf
Clinical Information
Phase 2
CAS Number
1229453-99-9
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6507399-01 0.1 mg
DGKB (Diacylglycerol Kinase beta, Diglyceride Kinase beta, DGK-beta, DAG Kinase beta, 90kD Diacylglycerol Kinase, DAGK2, KIAA0718)
Ask
View Details MBS6507399-02 5x 0.1 mg
DGKB (Diacylglycerol Kinase beta, Diglyceride Kinase beta, DGK-beta, DAG Kinase beta, 90kD Diacylglycerol Kinase, DAGK2, KIAA0718)
Ask
View Details